Katy Mason, Lancaster University
This short film reports on a study at the Stevenage Bioscience Catalyst (SBC) to look at the emerging business modelling practices of this start-up. SBC’s activities are helping to innovate the UK’s bioscience industry and health markets by acting as an incubator, connector and catalyst for change. SBC’s management team are acting in ‘entrepreneurial ways’, adopting relatively loose formal controls by circulating and developing a strong vision shared between funders, managers and other stakeholders (including GlaxoSmithKline, Wellcome Trust and BIS). The SBC site is designed to foster collaboration and interaction between tenant companies with the intention that the combination of opportunity and cooperation will generate innovation and commercial success. This study maps the unfolding activities of SBC. Finding explain how SBC’s business modelling practices are constructing new understandings of markets, socialising scientists into markets in particular ways and in doing so are connecting and integrating the communities’ market and business models. Our findings suggest that these, market, marketing and management practices are beginning to generate new economic models for health and wellbeing markets.